Live China, EU retaliate as Trump's massive tariffs kick in across the world. See the latest. Dusseldorf - Delayed Quote • EUR Karyopharm Therapeutics Inc (25K.DU) Follow Compare 0.5440 +0.0052 +(0.97%) As of February 25 at 7:30:21 PM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 25K.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 25K.DU View More All News Press Releases SEC Filings Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Karyopharm Announces 1-for-15 Reverse Stock Split Karyopharm Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Call Highlights: Navigating Revenue ... Q4 2024 Karyopharm Therapeutics Inc Earnings Call Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates Karyopharm Therapeutics: Q4 Earnings Snapshot Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025